BlackRock Advisors’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $6.43M | Buy |
1,691,107
+7,087
| +0.4% | +$26.9K | 0.01% | 1007 |
|
|
2016
Q3 | $15.1M | Sell |
1,684,020
-1,314
| -0.1% | -$11.8K | 0.02% | 637 |
|
|
2016
Q2 | $11.9M | Buy |
1,685,334
+99,697
| +6% | +$701K | 0.01% | 745 |
|
|
2016
Q1 | $13.5M | Buy |
1,585,637
+78,220
| +5% | +$665K | 0.01% | 663 |
|
|
2015
Q4 | $19.8M | Sell |
1,507,417
-51,335
| -3% | -$674K | 0.02% | 539 |
|
|
2015
Q3 | $5.71M | Sell |
1,558,752
-768,264
| -33% | -$2.81M | 0.01% | 1024 |
|
|
2015
Q2 | $13.4M | Sell |
2,327,016
-459,008
| -16% | -$2.64M | 0.01% | 654 |
|
|
2015
Q1 | $16.3M | Sell |
2,786,024
-373,193
| -12% | -$2.18M | 0.02% | 617 |
|
|
2014
Q4 | $24.8M | Buy |
3,159,217
+95,227
| +3% | +$747K | 0.02% | 486 |
|
|
2014
Q3 | $15M | Buy |
3,063,990
+120,845
| +4% | +$593K | 0.02% | 637 |
|
|
2014
Q2 | $18.2M | Buy |
2,943,145
+281,929
| +11% | +$1.74M | 0.02% | 579 |
|
|
2014
Q1 | $14.2M | Buy |
2,661,216
+534,141
| +25% | +$2.86M | 0.01% | 651 |
|
|
2013
Q4 | $11.1M | Buy |
2,127,075
+1,416,914
| +200% | +$7.41M | 0.01% | 744 |
|
|
2013
Q3 | $3.92M | Buy |
710,161
+4,145
| +0.6% | +$22.9K | ﹤0.01% | 1011 |
|
|
2013
Q2 | $1.79M | Buy |
+706,016
| New | +$1.79M | ﹤0.01% | 1148 |
|